Virological tools to diagnose and monitor hepatitis C virus infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

R. Cavallo Clinical Microbiology and Infection

Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C C. Sagnelli, M. Merli, C. Uberti-Foppa, H. Hasson,

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care S. Chevaliez,

Herpes zoster in non-hospitalized children

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Infectious causes of cancer: an evolving educational saga

R. Cantón Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Surveillance of Legionnaires’ disease in Austria

Vector control: a cornerstone in the malaria elimination campaign

J. Logar, B. Šoba, T. Premru-Sršen, Ž. Novak-Antolič

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels B. Sarov, L. Novack, N.

CMI editorial report 2011 Clinical Microbiology and Infection

Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.

Occupational transmission of hepatitis C virus resulting from use of the same supermarket meat slicer L. Bocket, S. Chevaliez, N. Talbodec, A. Sobaszek,

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Acute schistosomiasis, a diagnostic and therapeutic challenge

Metagenomics and probiotics

Hepatitis B and C virus-related carcinogenesis

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Factors related to the chronicity and evolution of hepatitis C infection in patients co- infected by the human immunodeficiency virus R. Pérez-Cano, C.

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology.

Current experience in treating invasive zygomycosis with posaconazole

A.P. Underwood, J. Green Clinical Microbiology and Infection

Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy L. Boglione,

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

F. Ceccherini-Silberstein, V. Cento, V. Calvez, C.-F. Perno

Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS M. Rybicka,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger

N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

New patterns of HIV-1 resistance during HAART

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients D. He, S. Guo, P. Zhu, S. Tao, M. Li,

Presentation transcript:

Virological tools to diagnose and monitor hepatitis C virus infection S. Chevaliez Clinical Microbiology and Infection Volume 17, Issue 2, Pages 116-121 (February 2011) DOI: 10.1111/j.1469-0691.2010.03418.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Kinetics of virological markers during acute (a) and chronic (b) hepatitis C virus (HCV) infection. Clinical Microbiology and Infection 2011 17, 116-121DOI: (10.1111/j.1469-0691.2010.03418.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Algorithms for the use of hepatitis C virus (HCV) virological tools in the treatment of chronic hepatitis C, according to the HCV genotype. Clinical Microbiology and Infection 2011 17, 116-121DOI: (10.1111/j.1469-0691.2010.03418.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions